Kelsey Gilliam
Family · Wichita, KSNPI 1932876455
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 397 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,097, more than ten times the $124 reported in 2021. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 397 payments — averaging $11.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$718
- AbbVie$669
- Pfizer$522
- AstraZeneca$491
- Novo Nordisk$382
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$264
- plus $1K from 26 others
What the payments were for
- Food & beverage$4,545100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 61 | $718 |
| AbbVie | 111 | $669 |
| Pfizer | 68 | $522 |
| AstraZeneca | 14 | $491 |
| Novo Nordisk | 44 | $382 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $264 |
| Amgen | 19 | $221 |
| Sumitomo Pharma America, Inc. | 8 | $137 |
| Alnylam Pharmaceuticals Inc. | 1 | $124 |
| GSK | 6 | $108 |
| Boehringer Ingelheim | 5 | $101 |
| Novartis | 4 | $72 |
| Lundbeck LLC | 4 | $68 |
| Corcept Therapeutics | 4 | $68 |
| Antares Pharma, Inc. | 4 | $67 |
| Radius Health, Inc. | 3 | $65 |
| Medtronic | 2 | $60 |
| Nevro Corp. | 2 | $50 |
| Insulet Corporation | 2 | $44 |
| Axsome Therapeutics, Inc. | 3 | $43 |
| Dexcom, Inc. | 2 | $39 |
| Globus Medical | 1 | $32 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $31 |
| Johnson & Johnson | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Bayer | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Merck | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,545 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 48 | $778 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $671 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $354 |
| Doxycycline Hyclate | 48 | $335 |
| Pantoprazole Sodium | 63 | $271 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $251 |
| Mupirocin | 27 | $236 |
| Cephalexin | 52 | $233 |
| Fluticasone Propionate | 22 | $204 |
| Methylprednisolone | 37 | $201 |
| Gabapentin | 11 | $148 |
| Meloxicam | 89 | $145 |
| Famotidine | 26 | $144 |
| Atorvastatin Calcium | 22 | $137 |
| Ondansetron OdtOndansetron | 13 | $129 |
Paid to pharmacies, not to this prescriber.
Other family in Wichita
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Mary GonzalesWichita$87K
- Mary GarciaWichita$24K
- Jennifer NeelWichita$15K
- Amanda AstWichita$9K
- Jennifer MartinWichita$8K
- Lauren CoteWichita$7K
- Mimi TranWichita$6K
- Kara NabboutWichita$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.